Health Condition 1: N979- Female infertility, unspecified
Conditions
Interventions
Intervention1: INJ BETA HCG 5000 IU IM: HCG trigger is given once ovum has reached optimum levels of perifollicular flow and flow parameters
Duration - 1 month
Control Intervention1: INJ BETA HCG 50
Sponsors
Saveetha medical college
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of infertility requiring assisted reproductive treatments (ART). Willingness to use the designated mobile application for ovum quality prediction and consultation. Ability to provide informed consent. Basic proficiency in using smartphones or willingness to learn. Medically cleared for ART treatments, including HCG trigger administration. Availability for scheduled clinic visits and follow-up appointments. Ownership of smartphone with internet access
Exclusion criteria
Exclusion criteria: Refusal or inability to use the designated mobile application for ovum quality prediction and consultation throughout the study. Presence of medical conditions or treatments that contraindicate participation in assisted reproductive treatments (ART). Concurrent participation in other clinical studies that could confound study outcomes. Inability to provide informed consent or comprehend study procedures adequately. Significant cognitive impairment or language barriers impairing participation and data collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accurately predict the timing of beta hcg triggerTimepoint: This study uses perifollicular blood flow to optimize HCG trigger timing, comparing mobile app monitoring with conventional methods. Key time points include baseline assessment (Day 2-3), follicular monitoring (Day 8-10 onward), pre-HCG evaluation (24-36 hours before trigger), HCG trigger administration, post-trigger monitoring (24-48 hours after), and outcome assessment (7-14 days post-trigger). The goal is to improve ovum quality and patient satisfaction. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome is to assess patient compliance, satisfaction, & convenience between mobile app-based monitoring & conventional consultation.Timepoint: Key time points include baseline satisfaction survey (cycle start), adherence tracking during follicular monitoring (Day 8-10 onwards), patient experience evaluation post-HCG trigger (24-48 hours after), & a final satisfaction survey (7-14 days post-trigger). | — |
Countries
India
Contacts
Public ContactKavya P
Saveetha medical college and hospital
Outcome results
None listed